Creating Clones, Kids & Chimera: Liberal Democratic Compromise at the Crossroads

Adams, Nathan A.
June 2004
Issues in Law & Medicine;Summer2004, Vol. 20 Issue 1, p3
Academic Journal
The objective of this article is to find middle ground between the supporters and opponents of biotechnology by perpetuating the existing legal compromise pertainang to the complete range of health and welfare doctrines relevant to the biotechnological industry. The author aspires neither to add to nor detract from this liberal democratic consensus, hut to preserve its Constitutive balance between positivism and natural law and over-regulation and under-regulation in the hopes of stabilizing new political fault lines developing around the few biotechnological innovations already grabbing headlines. The most feasible solution is to extend the existing liberal democratic compromise with respect to equal protection, reproductive rights, the First Amendment, human subject experimentation, patent law, and parental rights. This includes banning or monopolizing certain biotechnologies and extending substantive special respect to the in vivo living human embryo. Biotechnology must not be left to regulate itself.


Related Articles

  • Agricultural Biotechnology and the Future Benefits Argument. Jeffrey Burkhardt // Journal of Agricultural & Environmental Ethics;Jun2001, Vol. 14 Issue 2, p135 

    In the face of criticisms about the current generation of agricultural biotechnology products, some proponents of agricultural biotechnology offer a ``future benefits argument''(FBA), which is a utilitarian ethical argument that attempts to justify continued R&D. This paper analyzes several...

  • An embryonic nation. Xiangzhong Yang // Nature;3/11/2004, Vol. 428 Issue 6979, p210 

    Explores the potential of human-embryo technology in China. Religious and ethical issues on the use of animal or human embryos; China's opposition to reproductive human cloning; Governmental and public recognition of biotechnologies.

  • Biotech leading technology charge. Brandon, Hembree // Southeast Farm Press;5/19/2004, Vol. 31 Issue 14, p30 

    Focuses on the rapid evolution of agricultural biotechnology as farmers in the Southeast area in the U.S. capitalize on its production enhancements and cost-effectiveness. Acceptance of genetically engineered crops; Utilization of new technologies in order to stay competitive in world markets;...

  • Biotechs Keep Bouncing Back To Top Slot. PAUL WHITFIELD // Investors Business Daily;10/23/2014, pB06 

    Biotechs keep coming back to the pole position, or near it.

  • Assessing public support for biotechnology in South Africa. Pouris, Anastassios // South African Journal of Science;Nov/Dec2003, Vol. 99 Issue 11/12, p513 

    This article reports on attitudes towards biotechnology by the South African public. A multi-criteria survey was used to examine trust in science and technology, the public's opinions of biotechnology, its knowledge of the field and the predisposition of the media towards science. While a...

  • I International Congress “Biotechnology: State of the Art and Prospects for Development”. Reshetilova, T. A. // Applied Biochemistry & Microbiology;May/Jun2003, Vol. 39 Issue 3, p333 

    Highlights the I International Congress entitled "Biotechnology: State of the Art and Prospects for Development," in Moscow, Russia on October 14-18, 2002. Organizers of the event such as the Russian Academy of Sciences, the Russian Academy of Medical Sciences, and the Russian Academy of...

  • bi·o·tech·nol·o·gy.  // American Heritage Student Science Dictionary;2009, p41 

    A definition of the term "biotechnology" is presented. It refers to a technology used by a living organism to solve an engineering problem or perform an industrial task. An example of biotechnology is using bacteria that feed on hydrocarbons to clean up an oil spill. Biotechnology also refers to...

  • Genetic nondiscrimination. Billings, Paul R. // Nature Genetics;Jun2005, Vol. 37 Issue 6, p559 

    The identification and investigation of sentinel cases has illuminated genetic discrimination in the US. Its occurrence impedes applications of biotechnology and is a primary focus of public policy activity at the federal level. Continued research and informed responses may make genetic...

  • Scaling Down of Biopharmaceutical Unit Operations -- Part 2: Chromatography and Filtration. Rathore, Anurag; Krishnan, Raj; Tozer, Stephanie; Smiley, Dave; Rausch, Steve; Seely, Jim // BioPharm International;Apr2005, Vol. 18 Issue 4, p58 

    Reports on the guidelines and examples for scale-down of common downstream unit operations by chromatography and filtration in biotech processes. Performance of feed stream characteristics to ensure a good match; Inclusion of some significant operational performance parameters; Statistical...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics